 | • レポートコード：B-MOR-08443 • 出版社/出版日：Mordor Intelligence / 2018年6月1日 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・製薬 |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、歯周病の世界市場について調べ、歯周病の世界規模、市場動向、市場環境、製品種類別（非外科的治療、外科的治療）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・歯周病の世界市場インサイト ・歯周病の世界市場環境 ・歯周病の世界市場動向 ・歯周病の世界市場規模 ・歯周病の世界市場規模：製品種類別（非外科的治療、外科的治療） ・歯周病の世界市場：地域別市場規模・分析 ・歯周病の北米市場規模・予測 ・歯周病のアメリカ市場規模・予測 ・歯周病のヨーロッパ市場規模・予測 ・歯周病のアジア市場規模・予測 ・歯周病の日本市場規模・予測 ・歯周病の中国市場規模・予測 ・歯周病のインド市場規模・予測 ・歯周病の韓国市場規模・予測 ・関連企業情報・競争状況 |
The periodontal market is expected to register a CAGR of 8.64%. The increasing aging population, growing medical and dental tourism in the developing markets and growing awareness about oral health contributes the market growth for periodontal market.
Increasing Aging Population
The increasing prevalence and severity of periodontal disease have been found associated with aging, which affects majority of the adult population over 50 years of age. Due to the increasing aging population there has been an increase in the large number of dental implants and oral surgeries being performed. Therefore, the aging population is accompanied by an increase in the prevalence and incidence of periodontal diseases, which contributes in the growth of the market, globally. The other factors also include growing medical and dental tourism in the developing markets and growing awareness about oral health.
Increase in Cost of Periodontal Surgeries
Periodontal surgery is considered as one of the most expensive dental treatments known today. The cost of periodontal surgery varies greatly depending on the type of procedure and the severity of the oral diseases. These gum disease treatments may cost between USD 500 and USD 10,000, which is a high cost and a restraining factor for the patients adopting it. Hence, many of the low and middle income countries are unable to adopt these surgeries due to high cost, which is restricting the growth of periodontal market.
Lack of proper reimbursement of dental care is also the factor, which is likely to impede the growth of periodontal market.
North America Dominates the Market
North America has a high burden of periodontal diseases in the adult United States population. Initiatives by local governments to improve oral care, especially for individuals suffering from untreated dental diseases are expected to drive the market in the region. However, the market in Asia Pacific is likely to expand at a considerable growth rate during the forecast period, due to exponential rise in the geriatric population and increase in awareness among consumers regarding oral health.
Key Developments in the Market
• February 2017: Denmat holdings, LLC launched the NV PRO3 microlaser next generation soft-tissue diode laser
• December 2017: Straumann Group acquired Same Day Solutions (SDS), a dental distribution company in Portugal
The major players includes- DEN-MAT HOLDINGS LLC, DENTSPLY SIRONA, DEXCEL PHARMA, 3M, MEDTRONIC, STRAUMANN, BIOHORIZONS, ZIMMER BIOMET INC, DANAHER CORPORATION and VALEANT PHARMACEUTICALS INTERNATIONAL INC., among others.
Reasons to Purchase this Report
• Current and future periodontal market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet in excel
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative who will ensure you get a report that suits your needs
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Aging Population
6.1.2 Growing Medical and Dental Tourism in Developing Markets
6.1.3 Growing Awareness about Oral Health
6.2 Market Restraints
6.2.1 Lack of Proper Reimbursement of Dental Care
6.2.2 Increase In Cost Of Periodontal Surgeries
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product Type
7.1.1 By Non-Surgical Treatment
7.1.1.1 By Therapy
7.1.1.1.1 Local Antibiotics
7.1.1.1.1.1 Arestin
7.1.1.1.1.2 Others
7.1.1.1.2 Systemic Antibiotics
7.1.1.1.2.1 Minocycline
7.1.1.1.2.2 Doxycycline
7.1.1.1.2.3 Others
7.1.1.2 By Laser Treatment
7.1.2 By Surgical Devices
7.1.2.1 Dental Bone Implants
7.1.2.1.1 Endosteal
7.1.2.1.2 Subperiosteal
7.1.2.2 Dental Bone Grafting
7.1.2.2.1 Allograft
7.1.2.2.2 Xenograft
7.1.2.2.3 Others
7.2 By Geography
7.2.1 North America
7.2.1.1 United States
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 France
7.2.2.2 Germany
7.2.2.3 United Kingdom
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 Japan
7.2.3.3 India
7.2.3.4 Australia & New Zealand
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa
7.2.4.1 GCC
7.2.4.2 South Africa
7.2.4.3 Rest of the Middle East & Africa
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 3M
9.2 Biohorizons
9.3 Danaher Corporation
9.4 Den-Mat Holdings, LLC
9.5 Dentsply Sirona
9.6 Dexcel Pharma
9.7 Medtronic
9.8 Straumann
9.9 Valeant Pharmaceuticals International, Inc
9.10 Zimmer Biomet Inc
**List Not Exhaustive
10. Future of the Market